↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

151 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 **comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter. - - - - 1件: 86 💬
2 0.5 mg budesonide effervescent tablet for orodispersible use Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
3 1 mg budesonide effervescent tablet for orodispersible use Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
4 120 mg sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
5 15 mg sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
6 1mg budesonide effervescent tablet for orodispersible use Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
7 25% mtd sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
8 2mg budesonide effervescent tablet for orodispersible use Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
9 4.2% nacl/inhalation solution - - - - 1件: 299 💬
10 45 mg sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
11 90 mg sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
12 Air001 (sodium nitrite inhalation solution) Nitrite - - - 1件: 86 💬
13 Air001 inhalation solution - - - - 1件: 86 💬
14 Air001 inhalation solution (expansion arm) - - - - 1件: 86 💬
15 Amiloride solution for inhalation Amiloride 2件: D00649, D07447 💬 3件: SCNN1A, SCNN1B, SCNN1G 💬 2件: Aldosterone-regulated sodium reabsorption, Taste transduction 1件: 299 💬
16 Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
17 Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
18 Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
19 Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
20 Azd5634 for inhalation - - - - 1件: 299 💬
21 Aztreonam for inhalation (ai) Aztreonam 2件: D00240, D06558 💬 - - 1件: 299 💬
22 Aztreonam for inhalation solution Aztreonam 2件: D00240, D06558 💬 - - 1件: 299 💬
23 Aztreonam for inhalation solution (azli) Aztreonam 2件: D00240, D06558 💬 - - 1件: 299 💬
24 Aztreonam lysine for inhalation Aztreonam 3件: D00240, D02304, D06558 💬 - - 1件: 299 💬
25 Aztreonam lysine for inhalation (azli) Aztreonam 3件: D00240, D02304, D06558 💬 - - 1件: 228 💬
26 Budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
27 Budesonide ( zentacort capsules 3mg ) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 96 💬
28 Budesonide (6 mg) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
29 Budesonide (9 mg) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
30 Budesonide 0.5mg orodispersible tablet twice daily Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
31 Budesonide 1mg orodispersible tablet twice daily Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
32 Budesonide 6 mg capsules, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
33 Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
34 Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
35 Budesonide 9 mg capsules, hard (bux-pv) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
36 Budesonide 9 mg capsules, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
37 Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
38 Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
39 Budesonide [0.4mg/ml] viscous suspension Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
40 Budesonide mmx Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
41 Budesonide mmx 6 mg tablet Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
42 Budesonide mmx® Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
43 Budesonide mmx® 6 mg Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
44 Budesonide mmx® 9 mg Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
45 Budesonide oral suspension Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
46 Budesonide oral suspension [0.2 mg/ml] Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
47 Budesonide plus prevacid Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
48 Budesonide-formoterol single inhaler Budesonide 4件: D00246, D01373, D05277, D07990 💬 2件: ADRB2, NR3C1 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 299 💬
49 Budesonide-mmx Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
50 Budesonide-mmx® Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
51 Budesonide-mmx® 6 mg Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
52 Budesonide-mmx® 9 mg Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
53 Budesonide-mmx™ Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
54 Budesonide/formoterol Budesonide 4件: D00246, D01373, D05277, D07990 💬 2件: ADRB2, NR3C1 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 228 💬
55 Ceftazidime and tobramycin Ceftazidime 4件: D00063, D00921, D02542, D07654 💬 - - 1件: 299 💬
56 Ciprofloxacin (bayq3939) dry powder for inhalation Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
57 Ciprofloxacin dispersion for inhalation Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
58 Ciprofloxacin for inhalation Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
59 Colimycine inhalation - - - - 1件: 299 💬
60 Combination oral budesonide and rectal hydrocortisone Budesonide 2件: D00088, D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
61 Cyclosporine a dry powder inhalation (drug) Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 228 💬
62 Cyclosporine inhalation solution Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 228 💬
63 Cyclosporine inhalation solution (cis) Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 228 💬
64 Denufosol tetrasodium (ins37217) inhalation solution Denufosol 1件: D03685 💬 - - 1件: 299 💬
65 Denufosol tetrasodium inhalation solution Denufosol 1件: D03685 💬 - - 1件: 299 💬
66 Device: l606 inhalation system - - - - 1件: 86 💬
67 Dry powder tobramycin Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
68 Formoterol/budesonide Budesonide 4件: D00246, D01373, D05277, D07990 💬 2件: ADRB2, NR3C1 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 228 💬
69 Gm-csf inhalation therapy - - - - 1件: 229 💬
70 Helium / oxygen mixed gas inhalation therapy Helium 2件: D00003, D04420 💬 - - 1件: 330 💬
71 Heparin 25mg inhalation powder, hard capsule Heparin 1件: D07510 💬 1件: SERPINC1 💬 1件: Complement and coagulation cascades 1件: 299 💬
72 High dose budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
73 High dose budesonide suspension Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
74 High dose budesonide tablet Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
75 High dose of budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 299 💬
76 Hyaluronic acid inhalation solution Hyaluronic acid 1件: D08043 💬 - - 1件: 231 💬
77 Iloprost inhalation solution (ventavis) Iloprost 1件: D02721 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 2件: 85, 86 💬
78 Inhalation - - - - 1件: 228 💬
79 Inhaled tobramycin Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
80 Inhaled/swallowed budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
81 Inomax 400ppm mol/mol inhalation gas - - - - 2件: 85, 299 💬
82 Iv tobramycin Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
83 Kamada -aat for inhalation or inhaled aat (aat) - - - - 1件: 231 💬
84 Kamada-aat for inhalation - - - - 1件: 231 💬
85 Kamada-aat for inhalation, 160mg - - - - 1件: 231 💬
86 Kamada-aat for inhalation, 80mg - - - - 1件: 231 💬
87 L606 (liposomal treprostinil) inhalation solution 51ug Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
88 Levodopa powder for inhalation Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
89 Liposomal amikacin for inhalation Amikacin 2件: D00865, D02543 💬 - - 1件: 299 💬
90 Liposomal amikacin for inhalation (arikayce™) using the pari investigational eflow® nebulizer. Amikacin 2件: D00865, D02543 💬 - - 1件: 299 💬
91 Low dose budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
92 Low dose budesonide tablet Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
93 Mannitol inhalation powder Mannitol 1件: D00062 💬 - - 1件: 299 💬
94 Methylprednisolone or budesonide Budesonide 7件: D00246, D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 96 💬
95 Mp-376 (levofloxacin solution for inhalation) Levofloxacin 2件: D00588, D08120 💬 - - 1件: 299 💬
96 Nebcin (tobramycin) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
97 Nebulization tobramycin Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
98 Nitric oxide for inhalation Nitric Oxide 1件: D00074 💬 - - 2件: 86, 299 💬
99 Oligog cf-5/20, 17,5 mg, hartkapsel mit pulver zur inhalation - - - - 1件: 299 💬
100 Oligog cf/20, 27,5 mg, hartkapsel mit pulver zur inhalation - - - - 1件: 299 💬
101 Oligog cf/20, 37,5 mg, hartkapsel mit pulver zur inhalation - - - - 1件: 299 💬
102 Oligog dry powder for inhalation - - - - 1件: 299 💬
103 Oral budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
104 Oral budesonide suspension (mb-9) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
105 Oral budesonide suspension (obs) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
106 Oral viscous budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
107 Oral viscous budesonide (ovb) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
108 Other: tobramycin time of administration Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
109 Radiolabelled oligog cf-5/20 dry powder for inhalation (dpi) - - - - 1件: 299 💬
110 Rt234 - vardenafil inhalation powder Vardenafil 3件: D02731, D03260, D08668 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
111 Saline 0.9% inhalation solution - - - - 1件: 299 💬
112 Sodium nitrite inhalation solution Nitrite - - - 1件: 86 💬
113 Spiriva respimat 2.5 microgram, solution for inhalation - - - - 1件: 299 💬
114 Tiotropium respimat 1.25 microgram solution for inhalation Tiotropium - - - 1件: 299 💬
115 Tiotropium respimat 1.25 microgram, solution for inhalation Tiotropium - - - 1件: 299 💬
116 Tiotropium respimat 1.25 micrograms solution for inhalation Tiotropium - - - 1件: 299 💬
117 Tip (tobramycin inhalation powder) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
118 Tis (tobramycin inhalation solution) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
119 Tobi (tobramycin) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
120 Tobi 300 mg/5 ml, solution pour inhalation par nébuliseur - - - - 1件: 299 💬
121 Tobi podhaler 28 mg hartkapseln mit pulver zur inhalation - - - - 1件: 299 💬
122 Tobramycin Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
123 Tobramycin (gernebcin®) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
124 Tobramycin / bramitob Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
125 Tobramycin / tobi Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
126 Tobramycin 100 pari Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
127 Tobramycin dry powder Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
128 Tobramycin for inhalation Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
129 Tobramycin inhalation powder Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
130 Tobramycin inhalation powder (tip) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
131 Tobramycin inhalation powder tip delivered by the t-326 inhaler Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
132 Tobramycin inhalation solution Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
133 Tobramycin inhalation solution (tis) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
134 Tobramycin inhalation solution using a pari lc® plus nebulizer. Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
135 Tobramycin injection 40mg/1ml Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
136 Tobramycin nebulized nasally Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
137 Tobramycin powder Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
138 Tobramycin solution for inhalation Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
139 Tobramycin solution for inhalation (tobi) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
140 Tobramycin solution for inhalation 300 mg Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
141 Tobramycin steri-neb 300 mg/5 ml, inhalation solution Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
142 Tobramycin sulfate Sulfate ion 2件: D00063, D02542 💬 - - 1件: 299 💬
143 Treprostinil inhalation powder Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
144 Treprostinil inhalations Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
145 Treprostinil sodium for inhalation Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 85 💬
146 Treprostinil sodium solution for inhalation Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
147 Tyvaso inhalation solution - - - - 1件: 86 💬
148 Vancomycin hydrochloride inhalation powder Vancomycin 2件: D00212, D00926 💬 - - 1件: 299 💬
149 Vancomycin inhalation powder Vancomycin 2件: D00212, D00926 💬 - - 1件: 299 💬
150 Vantobra (tobramycin) Tobramycin 2件: D00063, D02542 💬 - - 1件: 299 💬
151 Viscous/swallowed budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬

先頭へ